Mary Fretland

Title: Mary Fretland: Innovator in Pharmaceutical Formulations

Introduction

Mary Fretland is a notable inventor based in Eagan, MN (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of immune response modifiers. Her work is aimed at addressing various dermal associated conditions.

Latest Patents

Mary Fretland holds 1 patent for her invention titled "Pharmaceutical formulations comprising an immune response modifier." This patent includes formulations that utilize immune response modifiers chosen from a variety of chemical compounds, including imidazoquinoline amines and thiazolo-quinolineamines. These formulations are designed to be effective in treating conditions such as actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts.

Career Highlights

Mary Fretland is associated with 3M Innovative Properties Company, where she has been instrumental in advancing research and development in her field. Her innovative approach has led to the creation of novel topical formulations that provide therapeutic benefits for patients.

Collaborations

Mary has collaborated with notable colleagues, including Terri F Busch and Raymond D Skwierczynski. These partnerships have contributed to the success of her research and the development of her patented formulations.

Conclusion

Mary Fretland's contributions to pharmaceutical formulations highlight her role as an innovator in the field. Her work continues to impact the treatment of various skin conditions, showcasing the importance of research and development in healthcare.